The Battelle abstract indicates a conclusion of more MBS lab testing required, while the recent WM Phoenix abstract on the GTGP site concludes with a recommendation of MBS. Both presentations were given by Jody Bickford within a few weeks. Why the difference? Apparently, there has been some change in who owns the MBS rights, as well as another start-up company called "J3" has been formed that may be linked to GTGP. Apparently, it is implied that Fallacaro, GTGP CEO, is a part of J3. Also, apparently Bickford has changed jobs and is no longer employed by MSE, but now works for J3.

So, the difference in the Battelle abstract and recent WM Phoenix presentation may be because Fallacaro now has something to do with the presentation. The WM Phoenix presentation recommends MBS outright. Really not a true validation, if the same outfit is verifying it.

Also, no SEC filings or any PR. If the rumors and speculation are true, these material events must be filed with the SEC. Be careful in reading anything into a PR, should one appear. Financials are still a priority with this company, and the accountant/auditor has yet to be announced. Therefore, until an accountant/auditor is announced, it can be assumed the financials are not being done.